Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Pharmaceutical Wholesalers (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceutical Wholesalers (UK) report will tell you the companies that have ... Read More
-
Belgium Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Belgium) report will tell you the companies that have a declining financial ... Read More
-
India Pharmaceuticals and Medicine - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals and Medicine (India) report will tell you the ... Read More
-
Oral Solid Dosage Contract Manufacturing Global Market Report 2025
... solid dosage contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Cannabis Production in Canada - Industry Market Research Report
... in 2013, producers have grown continuously as they invest in production capabilities to produce quality products. As consumers shifted from illegal cannabis purchases to the licensed recreational market, cannabis growers have grown significantly, but revenue ... Read More
-
Oral Solid Dosage Pharmaceutical Formulation Global Market Report 2025
... solid dosage pharmaceutical formulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Bio/Pharmaceutical Outsourcing Report, March 2025
... outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing ... Read More
-
2025 Global Generic Active Pharmaceutical Ingredients Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
India API Management Market Databank
... to be the highest contributor to this market, with $95.1 Million in 2025, and is anticipated to reach $576.4 Million by 2032, registering a CAGR of 29.40%. Services segment is anticipated to reach $209.2 Million ... Read More
-
India API Market Databank
... expected to be the highest contributor to this market, with $2,360.2 Million in 2025, and is anticipated to reach $3,658.8 Million by 2032, registering a CAGR of 6.50%. Merchant API manufacturers segment is anticipated to ... Read More
-
Japan API Market Databank
... expected to be the highest contributor to this market, with $7,952.6 Million in 2025, and is anticipated to reach $11,417.4 Million by 2032, registering a CAGR of 5.34%. Merchant API manufacturers segment is anticipated to ... Read More
-
Mexico API Management Market Databank
... to be the highest contributor to this market, with $114.2 Million in 2025, and is anticipated to reach $778.5 Million by 2032, registering a CAGR of 31.60%. Services segment is anticipated to reach $259.8 Million ... Read More
-
North America API Management Market Databank
... expected to be the highest contributor to this market, with $1,449.0 Million in 2025, and is anticipated to reach $6,928.0 by 2032, registering a CAGR of 25.09%. Services segment is anticipated to reach $2,897.5 Million ... Read More
-
Rest of Asia API Management Market Databank
... is expected to be the highest contributor to this market, with $98.8 Million in 2025, and is anticipated to reach $640.8 Million by 2032, registering a CAGR of 30.65%. Services segment is anticipated to reach ... Read More
-
Brazil API Management Market Databank
... to be the highest contributor to this market, with $181.8 Million in 2025, and is anticipated to reach $1,098.1 Million by 2032, registering a CAGR of 29.34%. Services segment is anticipated to reach $395.7 Million ... Read More
-
France API Management Market Databank
... to be the highest contributor to this market, with $123.8 Million in 2025, and is anticipated to reach $683.7 Million by 2032, registering a CAGR of 27.70%. Services segment is anticipated to reach $257.6 Million ... Read More
-
Global API Databank Market Report
... to be the highest contributor to this market, with $128,145.7 Million in 2025, and is anticipated to reach $174,785.5 Million by 2032, registering a CAGR of 4.58%. Merchant API manufacturers segment is anticipated to reach ... Read More
-
UK API Market Databank
... expected to be the highest contributor to this market, with $4,701.4 Million in 2025, and is anticipated to reach $6,620.6 Million by 2032, registering a CAGR of 5.05%. Merchant API manufacturers segment is anticipated to ... Read More
-
Leading API Country Markets
... the highest contributor to this market, with $116,178.9 Million in 2025, and is anticipated to reach $157,492.5 Million by 2032, registering a CAGR of 4.48%. Asia-Pacific is anticipated to reach $52,802.7 Million by 2032 with ... Read More
-
Leading API Type of Synthesis Markets
... expected to be the highest contributor to this market, with $164,300.1 Million in 2025, and is anticipated to reach $223,582.1 Million by 2032, registering a CAGR of 4.54%. Biotech active pharmaceutical ingredients segment is anticipated ... Read More
-
Leading API Type of Drug Markets
... be the highest contributor to this market, with $195,911.2 Million in 2025, and is anticipated to reach $279,073.5 Million by 2032, registering a CAGR of 5.23%. Over-the-counter drugs segment is anticipated to reach $38,627.3 Million ... Read More
-
Packaging: United States
... such as chemicals, building construction, and consumer household goods. Total shipments are segmented by material as follows: paper; plastic; metal; and glass and other materials. To illustrate historical trends, total demand, total shipments, the various ... Read More
-
Portugal Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Portugal) report will tell you the companies that have a declining financial ... Read More
-
Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Delivery), End User (Pharmaceutical and Biotechnology Companies, Academics and Research Institutes), and Region 2025-2033
... during 2025-2033. Transfection reagents and equipment help modulate gene expression in eukaryotic cells in vitro and in vivo. They allow researchers to generate stable cell lines and introduce deoxyribonucleic acid (DNA) plasmids possessing gene inserts ... Read More
-
Leading API Therapeutic Application Markets
... be the highest contributor to this market, with $32,686.0 Million in 2025, and is anticipated to reach $53,438.4 Million by 2032, registering a CAGR of 7.30%. Oncology segment is anticipated to reach $51,872.8 Million by ... Read More
Research Assistance
